Tocilizumab for Patients With Cancer and COVID-19 Disease
Condition(s):Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm; Pneumonia; Pneumonitis; Severe Acute Respiratory Distress Syndrome; Symptomatic COVID-19 Infection Laboratory-ConfirmedLast Updated:July 20, 2021Terminated